![Kelly Larrabee](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Kelly Larrabee has worked as a Director-Clinical Services at ClearTrial LLC since 2010.
Kelly Larrabee active positions
Companies | Position | Start |
---|---|---|
ClearTrial LLC
![]() ClearTrial LLC Packaged SoftwareTechnology Services ClearTrial provides Clinical Trial Operations (CTO) software that makes the planning, forecasting, and tracking of clinical project and financial performance faster and more accurate. The ClearTrial system creates dramatic internal and supplier efficiencies and cost savings for their biopharmaceutical and medical device customers by integrating their clinical operations from Plan to Payment™. Top 20 biopharmaceutical companies, medical device companies, and small biotechs in the US, Europe, and Japan have all embraced their software. These organizations have come to rely on ClearTrial's industry intelligence, embedded clinical knowledge, and activity-based planning approach to add speed, flexibility, accuracy, and consistency to clinical development. | Chief Tech/Sci/R&D Officer | 08/02/2010 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
ClearTrial LLC
![]() ClearTrial LLC Packaged SoftwareTechnology Services ClearTrial provides Clinical Trial Operations (CTO) software that makes the planning, forecasting, and tracking of clinical project and financial performance faster and more accurate. The ClearTrial system creates dramatic internal and supplier efficiencies and cost savings for their biopharmaceutical and medical device customers by integrating their clinical operations from Plan to Payment™. Top 20 biopharmaceutical companies, medical device companies, and small biotechs in the US, Europe, and Japan have all embraced their software. These organizations have come to rely on ClearTrial's industry intelligence, embedded clinical knowledge, and activity-based planning approach to add speed, flexibility, accuracy, and consistency to clinical development. | Technology Services |
- Stock Market
- Insiders
- Kelly Larrabee